Received: 18 July 2020
Accepted: 4 September 2020
First Online: 17 September 2020
Ethics approval and consent to participate
: This project was approved by the Institutional Review Board (Study # 2019.410) of the Ochsner Medical Center, New Orleans, LA, USA. This study was exempted of signed consent from patients given its retrospective design. This raw data has not been published in any other article.
: Not applicable.
: SAM is a paid speaker for United Therapeutics Corporation and Bayer. All other authors declare no conflicts of interest related to this study.